Browse the full record of transactions filed by Hindman Andrew A., Chief Financial Officer. Insider active across 1 companies, notably Theravance Biopharma, Inc.. Cumulatively, 10 filings have been published. The latest transaction was filed on 20 May 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Andrew A. Hindman is Senior Vice President and Chief Financial Officer at Theravance Biopharma, Inc. He is responsible for the financial management of the company, overseeing accounting and financial operations.